The increase in the frequency of long-term respiratory conditions, such as respiratory allergies, asthma, and chronic obstructive pulmonary disease (COPD), among others, and the   The Global digital dose inhaler market is estimated to be valued at US$ 64.33 Bn in 2024 and is expected to exhibit a CAGR of 19% over the forecast period from 2024 to 2031.Key Takeaways Key players operating in...